Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Serological Assay for the Detection of Antibodies Generated Against California Serogroup Virus Infection.

Methods in molecular biology (Clifton, N.J.)·2024
Same author

Notification of Nontuberculous Mycobacteria: An Australian Perspective.

Annals of the American Thoracic Society·2017
Same author

To eliminate tuberculosis, we must universally encourage treatment of its latent form.

Respirology (Carlton, Vic.)·2015
Same author

Mass treatment to eliminate tuberculosis from an island population.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2015
Same author

Vitamin D and tuberculosis.

The Medical journal of Australia·2014
Same author

Invasive pneumococcal disease in Australia 2007 and 2008.

Communicable diseases intelligence quarterly report·2012

Related Experiment Video

Updated: Jun 17, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Tuberculosis notifications in Australia, 2007.

Christina Barry1, Anastasios Konstantinos,

  • 1Vaccine Preventable Diseases Surveillance Section, Office of Health Protection, Department of Health and Ageing, Canberra, Australian Capital Territory. christina.barry@health.gov.au

Communicable Diseases Intelligence Quarterly Report
|January 2, 2010
PubMed
Summary
This summary is machine-generated.

In 2007, Australia reported 1,135 tuberculosis (TB) cases, primarily among overseas-born individuals and Indigenous Australians. High treatment success rates highlight the importance of ongoing surveillance for TB control.

Related Experiment Videos

Last Updated: Jun 17, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Communicable Disease Surveillance

Background:

  • Tuberculosis (TB) remains a significant public health concern globally and in Australia.
  • Understanding the epidemiology of TB is crucial for effective control strategies.
  • The National Notifiable Diseases Surveillance System (NNDSS) provides vital data on TB trends.

Purpose of the Study:

  • To analyze the 2007 tuberculosis (TB) surveillance data in Australia.
  • To identify high-risk populations and risk factors for TB infection.
  • To assess treatment outcomes and inform future TB control efforts.

Main Methods:

  • Analysis of national TB notifications received by the NNDSS in 2007.
  • Calculation of TB incidence rates by population group (e.g., overseas-born, Indigenous Australians).
  • Review of reported risk factors and health care worker (HCW) cases.

Main Results:

  • A total of 1,135 TB notifications were recorded in 2007, with an overall incidence of 5.4 cases per 100,000 population.
  • The majority of cases (86.4%) occurred in the overseas-born population; incidence was significantly higher in Indigenous Australians (6.6/100,000) compared to non-Indigenous Australians (0.9/100,000).
  • Close contact and overseas residence were key risk factors; 31 HCW cases were reported, with no in-setting transmission.

Conclusions:

  • Tuberculosis in Australia disproportionately affects overseas-born individuals and Indigenous Australians.
  • Effective TB control requires targeted surveillance and interventions for at-risk populations.
  • Sustained centralized reporting is essential for monitoring trends and ensuring successful TB elimination.